For example, positive β-amyloid (Aβ) and tau proteins are important diagnostic criteria before and during the onset of AD, but they do not necessarily serve as biomarkers at other stages (Dubois et al., 2021). The gene discussed is MAPT; the disease is Alzheimer disease.